- The number of people getting diseases from ticks, mosquitoes and fleas has more than tripled in the U.S. in the last 13 years to 640,000, according to the Centers for Disease Control and Prevention.
- 80 percent of tick-borne diseases can cause long-lasting and debilitating symptoms.
- A new test, called Nanotrap, uses a urine sample to detect the bacteria that cause Lyme disease.
- Valneva's FDA fast-tracked Lyme disease vaccine, which works to stimulate an immune response in the body, will start Phase 2 clinical trials later this year.
In the midst of relaxing summer days and long-awaited vacations, there's a tiny enemy that's causing oversize worry: ticks.
Blacklegged ticks infected with the Lyme disease bacterium Borrelia burgdorferi are wreaking havoc in the northeastern, mid-Atlantic, and north-central states, as well as the West Coast, particularly in northern California. Lyme disease accounts for more than 80 percent of tick-borne diseases and, even if caught and treated, can cause long-lasting and debilitating symptoms.
In May the Centers for Disease Control and Prevention reported that the number of people getting diseases from ticks, mosquitoes and fleas has more than tripled in the United States, with more than 640,000 cases reported during the 13 years from 2004 through 2016.
In just the past year, celebrities Kelly Osbourne and The Real Housewives of Beverly Hills star Yolanda Hadid both released memoirs detailing their agonizing struggle with the disease and why it took so long for doctors to diagnose it. In fact, before finally testing positive for Lyme, Osbourne's doctors told her she had epilepsy.
But there are glimmers of hope, experts say. New tests to more accurately detect Lyme are in the works, including one that uses a urine sample to more quickly detect the presence of the bacteria that causes the disease. And last year a French company, Valneva, received fast-track status from the FDA for a vaccine for Lyme disease.
In the meantime, Lyme is affecting more people and is spreading to more states across the country. If left untreated, the disease can cause fever, fatigue, joint pain and eventually damage to the nervous system and heart. Fourteen states in the Northeast and upper Midwest, including Minnesota, Michigan, Maine and New Hampshire, have the greatest number of reported cases, according to the CDC, but nearly every state has been touched by it.
Researchers at the CDC say there are several reasons why Lyme is on the rise. For starters, we're a more mobile society. As goods and humans increasingly move around the world, ticks travel with them, introducing the disease to new locales quickly. Couple that with environmental changes, like global warming, and woefully inadequate prevention efforts on both the federal and state level, and it's no wonder why Amy Schwartz, an epidemiologist with the CDC's division of vector-borne diseases, said Lyme disease is "not going away anytime soon."
Making the disease even harder to battle, researchers say, is the fact that it is vastly underreported. Schwartz said about 30,000 cases of Lyme disease are reported in the United States each year (up from 10,000 a year in 1998), but about 300,000 cases annually are actually diagnosed, triple the amount from two decades ago. She said doctors are required to report cases of Lyme disease to their local health departments, but admits "that doesn't always happen."
Dorothy Leland, vice president for education and outreach at LymeDisease.org, a patient advocacy group, discovered that. She claimed that in 2005 her then 13-year-old daughter became quite ill. Doctors couldn't figure out the cause but ruled out Lyme because they told her the disease wasn't present in her home state of California. It took another year until Leland's daughter was diagnosed, but by then the teenager was so debilitated she spent three years in a wheelchair. "They wouldn't even go down the path of considering that it could have been Lyme, because they said it didn't happen in California," she said.
The other challenge with Lyme is that the available tests for it are not always accurate. As a result, people who have been bitten often suffer for months or, in the case of Hadid and Osbourne, for years until properly diagnosed.
Here's why: The current blood test for the disease relies on detecting antibodies. Those are the proteins the body's immune system produces to fight the disease. The test doesn't detect the disease itself.
The problem with this, said the CDC, is that a person isn't likely to test positive for Lyme until they've been infected for anywhere from four to six weeks. That's why doctors who suspect a patient has Lyme disease based on symptoms (rash, joint pain, and fatigue among them) should prescribe antibiotics even if the test is negative in the beginning.
A new test, called Nanotrap, is trying a different approach. Developed by Ceres Nanosciences — a privately-held company that lured investment by the Bill & Melinda Gates Foundation — the test uses a urine sample to detect the presence of the bacteria that causes Lyme disease. In early July, Nanotrap moved a step closer to FDA approval when the agency granted the test breakthrough device designation. This milestone means the FDA will work with Ceres to reduce the time it takes to get approval. The company estimates that can happen by late 2019.
But perhaps the greatest hope for eradicating the disease is with a vaccine. Valneva's FDA fast-tracked vaccine that works to stimulate an immune response in the body will start Phase 2 clinical trials later this year to determine the proper dosage. But even if all goes well, the French company's chief financial officer, David Lawrence, has been quoted as saying it likely will take another five years before the product is commercially available.
The company has estimated it could take $350 million to bring the vaccine to market and that it is now looking for a partner to help it with that financial investment.
An earlier vaccine, called Lymerix, was available from 1998 to 2002 but was voluntarily pulled from the market by its manufacturer, SmithKline Beecham (now GlaxoSmithKline) when class-action lawsuits alleged that it caused serious side effects, such as arthritis. Valneva claims the Phase 1 trials of its vaccine produced no serious side effects.
In the absence of more accurate diagnostic and treatment tools, many patients try a combination of drugs and other therapies, many of which the medical community doesn't exactly endorse. Kelly Osbourne revealed in her book that when she was finally accurately diagnosed with Lyme, she traveled to Frankfurt, Germany, where she underwent stem cell therapy and said she was cured.
More from Modern Medicine:
Heart disease is a becoming a big red state problem |
Why some women are adopting the Tom Brady diet
Proponents of stem cell therapy say it gives the body the ability to heal by allowing the stem cells to multiply and differentiate into healthier, more mature cells. Hadid also said she tried stem cell therapy, along with other holistic treatments, such as hyberbaric oxygen therapy, where a person breathes in pure oxygen in a pressured room or tube. She said she's in remission. In 2016 the 21st Century Cures Act allowed some stem cell products a faster and more flexible premarket approval process, but doctors here are not convinced that the therapy is effective in treating Lyme disease.
Doctors say that for now the best course of action is prevention. That means long pants and long sleeves when outside near wooded areas, bug repellent with DEET on exposed skin, and permethrin on shoes, socks and clothing. Before going inside, do a thorough search of the areas where ticks like to hide, such as behind the knees, on the scalp and near the armpits.
Check dogs for ticks, too. Although there are monthly medications for ticks, such as Frontline, that can be given to dogs to guard against Lyme, as well as a vaccine, the CDC said they still need to be checked for ticks because they can easily bring them into the house. "Right now prevention is so important," said Schwartz. "Until there's something else, this is our best defense."